What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“CaNCURE has helped to firm my interest in cancer medicine because it taught me the actual science behind a disease that presents itself in so many different ways. I love interacting with the cancer patients in our clinic because they are so humble and really teach me about taking life one day at a time.”

Marisa Wozniak, CaNCURE ’16


Trainee Spotlight


Catherine Nicholas

Health Science, '20

RHAMM splicing in multiple myeloma (MM) and its implications for immunotherapy

Ysaac Zegeye

Cell and Molecular Biology, '21

Using smart biomaterials with immunoadjuvants to treat metastatic breast cancer

Aviv Liani

Biology, '21

Impact of RPS15 mutation on development and progression of chronic lymphocytic leukemia

Featured Trainee Publication


Upcoming Events

Erythrocyte-Inspired Trojan Horse Systems for Drug Delivery

Tuesday, January 28, 2020

Zongmin Zhao, Ph.D. SEAS and Wyss Institute, Harvard University

115 Snell Library -- NEU, 3:25 PM


Mentor Spotlight


William Hahn, M.D., Ph.D.

Associate Professor of Medicine, HMS

We have a longstanding interest in cooperative genetic alterations that program malignant transformation and has developed many experimental model systems to study specific genetic alterations. Students will use therapeutic tumor-penetrating siRNA nanocomplexes to identify, validate, and understand potential therapeutic cancer.


Pasi Janne, M.D.

Director, Lowe Center for Thoracic Oncology,

Integrates bench-based studies with clinical trials of novel therapeutic agents. Students will test anti-cancer drugs in cells and tissues harvested from lung cancer patients, with the long-term goal of developing a rationale for individualizing patient therapy based on mutations


Trainee Spotlight


Aviv Liani

Biology, '21

Impact of RPS15 mutation on development and progression of chronic lymphocytic leukemia

Sagi Ravid

Chemical Engineering, '21

Enhanced delivery of camptothecin and doxorubicin conjugates with hyaluronic acid for the treatment of Glioblastoma using microbubble-mediated focused ultrasound

Catherine Nicholas

Health Science, '20

RHAMM splicing in multiple myeloma (MM) and its implications for immunotherapy


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...